% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Bauer:903194,
      author       = {Bauer, Elena Katharina and Werner, Jan-Michael and Fink,
                      Gereon R. and Langen, Karl-Josef and Galldiks, Norbert},
      title        = {{C}ase {R}eport: {D}etection of {S}ymptomatic
                      {T}reatment-{R}elated {C}hanges in a {P}atient {W}ith
                      {A}naplastic {O}ligodendroglioma {U}sing {FET} {PET}},
      journal      = {Frontiers in oncology},
      volume       = {11},
      issn         = {2234-943X},
      address      = {Lausanne},
      publisher    = {Frontiers Media},
      reportid     = {FZJ-2021-04913},
      pages        = {735388},
      year         = {2021},
      abstract     = {Following local and systemic treatment of gliomas, the
                      differentiation between glioma relapse and treatment-related
                      changes such as pseudoprogression or radiation necrosis
                      using conventional MRI is limited. To overcome this
                      limitation, various amino acid PET tracers such as
                      O-[2-(18F)-fluoroethyl]-L-tyrosine (FET) are increasingly
                      used and provide valuable additional clinical information.
                      We here report neuroimaging findings in a clincally
                      symptomatic 53-year-old woman with a recurrent anaplastic
                      oligodendroglioma with MRI findings highly suspicious for
                      tumor progression. In contrast, FET PET imaging suggested
                      treatment-related changes considerably earlier than the
                      regression of contrast enhancement on MRI. In patients with
                      oligodendroglioma, the phenomenon of symptomatic
                      treatment-related changes is not well described, making
                      these imaging findings unique and important for clinical
                      decision-making.},
      cin          = {INM-3 / INM-4},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {34868923},
      UT           = {WOS:000726120200001},
      doi          = {10.3389/fonc.2021.735388},
      url          = {https://juser.fz-juelich.de/record/903194},
}